(Q39890986)
Statements
PKCbeta is essential for the development of chronic lymphocytic leukemia in the TCL1 transgenic mouse model: validation of PKCbeta as a therapeutic target in chronic lymphocytic leukemia (English)
Claudia Holler
Josefina D Piñón
Christoph Heyder
Sebastian Hofbauer